HIV/AIDS
Infectious Disease·MeSH: Acquired Immunodeficiency Syndrome
Prevalence
550.1 / 100K
Incidence
26.6 / 100K/yr
2 drugs in development·2 companies·12 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| mytesi | Jaguar Health, Inc. (JAGX) |
Preclinical(1)
| Drug | Company |
|---|---|
| rpi-mn | NUTRA PHARMA CORP (NPHC) |
Compare drugs
Frequently asked questions
How many drugs are in development for HIV/AIDS?
BioSniper tracks 2 drugs in development for HIV/AIDS across 2 companies.
How many clinical trials target HIV/AIDS?
There are 12 clinical trials targeting HIV/AIDS tracked by BioSniper.
What is the prevalence of HIV/AIDS?
The estimated prevalence of HIV/AIDS is approximately 550.1 per 100,000 population.
Deep-dive into HIV/AIDS
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis